Why So Many Donor Organs Are Lost and How CMS Plans to Fix the System
About 1 in 5 recovered organs are discarded, including many that could have been transplanted. CMS is proposing stricter oversight of the 56 U.S. organ procurement organizations to reduce wasted organs, tighten quality and safety standards, and make transplant performance more consistent nationwide…
Tegoprubart: A Next-Generation Anti-Rejection Therapy
Before 1994, kidney transplant failure within five years was common. Tacrolimus improved survival, but serious side effects and long-term organ damage became widely accepted as inevitable. Now, a new drug suggests transplant medicine may be entering its next phase without the same cost to the body…
Inside UCLA’s Effort to End Required Lifelong Transplant Anti-Rejection Drugs
For decades, surviving a transplant has meant taking powerful anti-rejection drugs for life. A UCLA clinical trial using donor stem cells is testing whether retraining the immune system could finally change that tradeoff…